Accelerate Diagnostics Balance Sheet - Annual (NASDAQ:AXDX)

Add to My Stocks
$23.1 $0.45 (1.91%) AXDX stock closing price Mar 29, 2017 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Accelerate Diagnostics, and helps in stock analysis. As in our Accelerate Diagnostics stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results are typically accompanied with the company releasing financial statements. Accelerate Diagnostics operating cash flow was $-35.12M while Accelerate Diagnostics revenue stood at $0.14M. View latest and last 10 year balance sheet data to check Accelerate Diagnostics financial performance..

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011 2010 2009 2008 2007
Marketable Securities11.83M13.11M11.95M------
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets1.65M0.34M0.13M0.01M0.01M0.01M0.01M0.01M0.01M
Accelerate Diagnostics Total Current Assets
Property Plant & Equipment7.9M3.98M1.67M0.48M-----
Accumulated Depreciation2.88M1.44M0.62M0.34M-----
Accelerate Diagnostics Net Property Plant & Equipment
Investment & Advances----1.37M1.22M1.19M1.09M1.14M
Other Non-Current Assets----0.74M1.32M---
Deferred Charges---------
Deposits & Other Assets---------
Accelerate Diagnostics Total Assets
Notes Payable---------
Accounts Payable2.62M2.12M0.54M0.29M0.05M0.06M0.03M0.06M0.11M
Current Portion Long-Term Debt---------
Current Portion Capital Leases0.01M0.14M-------
Accrued Expenses2.54M0.49M0.51M0.87M0.03M0.03M0.04M0.03M0.04M
Income Taxes Payable---------
Other Current Liabilities0.12M0.01M0.08M0.07M0.1M0.01M0.07M0.11M0.09M
Accelerate Diagnostics Total Current Liabilities
Deferred Taxes/Income1M1.01M0.77M-1.39M1.31M1.2M1.11M1.15M
Convertible Debt---------
Long-Term Debt---------
Non-Current Capital Leases-0.01M-------
Other Long-Term Liabilities---------
Accelerate Diagnostics Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net0.05M0.04M0.04M0.02M14.33M14.13M13.96M13.8M12.87M
Capital Surplus243.89M131.35M75.93M31.24M1.51M1.16M0.96M1.01M0.65M
Retained Earnings-110.91M-65.41M-34.48M-19.2M-10.92M-10.04M-11.16M-10.26M-8.84M
Treasury Stock---------
Other Liabilities-0.01M0.01M0.02M--0.27M-0.27M-0.27M-0.27M-0.27M
Accelerate Diagnostics Shareholders Equity
Accelerate Diagnostics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

Apart from balance sheet items, an investor would do well to keep track of the Accelerate Diagnostics stock price by looking at Accelerate Diagnostics historical stock prices. One can compare PE with industry average by looking at the Accelerate Diagnostics PE ratio chart. The common balance sheet items are:
  • Assets: AXDX total assets, which was at $139.32M for 2015 is a balance sheet item representing value of what Accelerate Diagnostics owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Accelerate Diagnostics for 2015 total to $6.3M. Liabilities for a company like Accelerate Diagnostics include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Accelerate Diagnostics Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio